Personal History:Dr. Feigenberg received his B.S. in Chemical Engineering from Drexel University in 1991. He received his medical degree from Hahnemann University School of Medicine in 1997. He completed an internship in Internal Medicine at Temple University Hospital in Philadelphia and residency in Radiation Oncology at the University of Florida in Gainesville. Since completing his training, he worked at Fox Chase Cancer Center in Philadelphia where his clinical and research interests focused on lung cancer, head and neck cancer with a special interest in stereotactic body radiotherapy.
In 2009, he was recruited to University of Maryland’s Department of Radiation Oncology to lead the stereotactic body radiotherapy program, specifically to focus on tumors in the lung, liver and breast.
Research Interests:Dr. Feigenberg’s current interest continues to be centered around stereotactic radiotherapy and developing non-invasive methods to predict treatment responses. This is of utmost importance now that we are comparing this approach to surgery. Trying to develop early surrogates of treatment response are imperative to allow early surgical salvage if/when necessary. We are also investigating the mechanism of this novel technique which appears to be related to stimulating the immune system causing one’s body to fight tumor cells.
Selected Recent Publications
Wang L, Hayes S, Paskalev K, Jin L, Buyyounouski M, Ma M, Feigenberg, S. Dosimetric comparison of stereotactic body radiotherapy using 4D CT and multiphase CT images for treatment planning of lung cancer: Evaluation of the impact on daily dose coverage. Radiotherapy and Oncology, (In Press) 2010.
Movsas B, Langer CJ, Ross HJ, Wang LH, Jotte RM, Feigenberg S, Xu F, Huang CH, Monberg MJ, Obasaju CK. Randomized phase II trial of cisplatin, etoposide and radiation followed by gemcitabine alone or combined gemcitabine and docetaxel in stage III A/B unresectable non-small cell lung cancer. Journal of Thoracic Oncology, (In press) 2010.
Rusthoven K, Kavanagh B, Cardenes H, Stieber V, Burri S, Feigenberg S, Chidel M, Pugh T, Franklin W, Kane M, Gaspar L, Schefter T. Mature Results of a Multi-Institutional Phase I/II trial of Stereotactic Body Radiation Therapy for liver metastases. Journal of Clinical Oncology Vol. 27 (10), 1572-1578, 2009.
Ettinger DS, Bepler G, Bueno R, Chang A, Chang JY, Chirieac LR, D'Amico TA, Demmy TL, Feigenberg SJ, Grannis FW Jr, Jahan T, Jahanzeb M, Kessinger A, Komaki R, Kris MG, Langer CJ, Le QT, Martins R, Otterson GA, Robert F, Sugarbaker DJ, Wood DE; National Comprehensive Cancer Network (NCCN). Non-small cell lung cancer. J Natl Compr Canc Netw. Mar; 6(3):228-69, 2008.
Sharma NK, Ruth K, Konski AA, Buyyounouski MK, Nicolaou N, Lally BE, Morsas B, Yu JQ, Feigenberg SJ. Low morbidity and excellent local control using image guided Stereotactic Body Radiation Therapy (IGABRT) for lung tumors. Int. J Rad Oncol Biol Phys 72 (1), (S454),2008.
Feigenberg SJ, Sharma N, Wang L, Cohen R, Buyyounouski M, Lally B, Movsas B. Phase I dose escalation trial of image guided Stereotactic Body Radiotherapy for lung tumors. Int. J Rad Oncol Biol Phys 72(1),(S114), 2008.
Jin L, Wang L, Li J, L W, Feigenberg SJ, Ma C-M. Investigation of optimal beam margins for stereotactic radiotherapy of lung-cancer using Monte Carlo dose calculations. Phys.Med.Biol, 52:3549-3561, 2007.
Scott WJ, Howington J, Feigenberg SJ, Movsas B, Pisters K. Treatment of non-small cell lung cancer stage I and stage II: ACCP evidence-based clinical practice guidelines (2nd edition) Chest 132(3Suppl): 234S -242S, 2007.
Feigenberg SJ, Hanlon A, Langer C, Goldberg M, Nicolaou N, Millenson M, Coia L, Lanciano R and Movsas B. A phase II Trial of Concurrent Paclitaxel and Carboplatin and Thoracic Radiotherapy in Resected Stage II and IIIA Non-Small Cell Lung Carcinoma. J Thorac Oncol, 2(4):287-292, 2007.
Langer C, Somer R, Litwin S, Feigenberg SJ, Movsas B, Maiale C, Sherman E, Millenson M, Nicolaou N, Huang C and Treat J. Phase I study of radical thoracic radiation, weekly Irinotecan and Cisplatin in locally advanced non-small cell lung carcinoma (LA-NSCLC). J Thoracic Oncol, 2(3):203-209, 2007.
Chang DT, Feigenberg SJ, Indelicato DJ, Mendenhall NP, Morris CG, Lightsey J, Grobmyer SR, Copeland EM 3rd. Long-term outcomes in breast cancer patients with 10 or more positive axillary nodes treated with combined-modality therapy: The importance of radiation field selection. Int J Radiat Oncol Biol Phys,67(4):1043-1051, 2007.
Feigenberg SJ, Paskalev K, McNeeley S, Horwitz E, Konski A, Wang L, Ma C, Pollack. A. Comparing computed tomography localization with daily ultrasound during image-guided radiation therapy for the treatment of prostate cancer: a prospective evaluation. J Appl Clin Med Phys, 8 (3), 2268, 2007.
Wang L, Feigenberg SJ, Paskalev K, Chen L, Ma C. Benefit of 3-D image-guided stereotactic localization in the hypofractionated treatment of lung cancer. Int J Radiat Oncol Biol Phys 66(3):738-47, 2006.
Ettinger DS, Bepler G, Bueno R, Chang A, Chang JY, Chirieac LR, D'Amico TA, Demmy TL, Feigenberg SJ, Grannis FW Jr, Jahan T, Jahanzeb M, Kessinger A, Komaki R, Kris MG, Langer CJ, Le QT, Martins R, Otterson GA, Robert F, Sugarbaker DJ, Wood DE; National Comprehensive Cancer Network (NCCN). Non-small cell lung cancer clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2006 Jul; 4(6):548-82.
Paskalev K, Feigenberg SJ, Wang L, Movsas B, Laske D, Ma C. A method for repositioning of stereotactic patients with the aid of real-time CT image guidance. Phys Med Biol 50:N201-207, 2005.
Wang L, Movsas B, Jacob R, Fourkal E, Chen L, Price B, Feigenberg SJ, Konski A, Pollack A, Ma C. Stereotactic IMRT for Prostate Cancer: Setup Accuracy of a new Stereotactic Body Localization System. J Appl Clin Med Phys, 5(2) 18-28, 2004.
Feigenberg SJ, Mendenhall NP, Benda RK, Morris CG. Postmastectomy Radiation Therapy: Patterns of Recurrence and Long-Term Disease Control using Electrons. Int J Radiat Oncol Biol Phys, 56(3): 716-725, 2003.
Monroe A, Feigenberg SJ, Mendenhall NP. Angiosarcomas after Breast Conservation. Cancer, 97: 1832-40, 2003.
Feigenberg SJ, Mendenhall NP, Reith JD, Ward JR, Copeland EM. Angiosarcoma after Breast Conserving Therapy: Role for Hyperfractionated Radiotherapy. Int J Radiat Oncol Biol Phys 52(3): 620 – 626, 2002.
Faculty members: Update your contact information and create a profile.